The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Morgan Henry since 2009.
The trader's CIK number is 1375327.
At the time of the last reporting, Morgan Henry was the Director of Biospecifics Technologies Corp. (stock ticker symbol BSTC).
Also see all insider trading activities at Biospecifics Technologies Corp.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2014 | BSTC | 0 | $0 | 60,000 | $1,597,569 | 75,000 | $72,450 |
| 2013 | BSTC | 0 | $0 | 20,000 | $369,471 | 0 | $0 |
| 2012 | BSTC | 0 | $0 | 0 | $0 | 5,425 | $5,425 |
| 2009 | BSTC | 0 | $0 | 11,760 | $353,437 | 20,000 | $35,640 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2014-06-06 | BSTC | Option Ex | 15,000 | .83 | 12,450 |
| 2014-06-03 | BSTC | Sale | 816 | 27.00 | 22,032 |
| 2014-06-04 | BSTC | Sale | 17,124 | 27.00 | 462,348 |
| 2014-05-30 | BSTC | Sale | 337 | 27.02 | 9,106 |
| 2014-06-02 | BSTC | Sale | 1,723 | 27.01 | 46,543 |
| 2014-05-28 | BSTC | Sale | 8,247 | 27.03 | 222,891 |
| 2014-05-29 | BSTC | Sale | 11,753 | 27.04 | 317,789 |
| 2014-05-21 | BSTC | Option Ex | 40,000 | 1.00 | 40,000 |
| 2014-05-19 | BSTC | Sale | 20,000 | 25.84 | 516,860 |
| 2014-05-14 | BSTC | Option Ex | 20,000 | 1.00 | 20,000 |
| 2013-09-04 | BSTC | Sale | 12,402 | 18.55 | 230,057 |
| 2013-09-05 | BSTC | Sale | 5,448 | 18.35 | 99,970 |
| 2013-08-30 | BSTC | Sale | 946 | 18.30 | 17,311 |
| 2013-09-03 | BSTC | Sale | 1,204 | 18.38 | 22,133 |
| 2012-09-14 | BSTC | Option Ex | 5,425 | 1.00 | 5,425 |
| 2009-12-15 | BSTC | Sale | 306 | 30.31 | 9,274 |
| 2009-12-11 | BSTC | Sale | 11,254 | 30.04 | 338,092 |
| 2009-12-14 | BSTC | Sale | 200 | 30.36 | 6,071 |
| 2009-12-11 | BSTC | Option Ex | 20,000 | 1.78 | 35,640 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Morgan Henry (Director of Biospecifics Technologies Corp at the time of this reporting) see the Securities and Exchange Commission (SEC) website.